Basic Information
RNALocate ID: RLID:11001951
RNA Symbol: hsa-miR-185-5p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-185
RNA ID: miRBase:MIMAT0000455
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23539611
Tissue/Cell Line: Seminal plasma
Method: Microarray
Description: In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001842 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001843 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001844 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01001845 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:11001942 Exosome Plasma 29130611
RLID:11001943 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001944 Exosome Breast milk 22211110
RLID:11001945 Exosome Brain tissue 23382797
RLID:11001946 Exosome Plasma 23663360
RLID:11001947 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001948 Exosome Serum 25135963
RLID:11001949 Extracellular vesicle HEK-293T cells 22849433
RLID:11001950 Microvesicle Plasma 23077538
RLID:11001952 Microvesicle Follicular fluid 23666971
RLID-D:11000100 Exosome Blood|Tongue tissue
RLID-D:11000383 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-185-5p Idiopathic pulmonary fibrosis MNDR-E-MI-20977
MNDR hsa-miR-185-5p Medulloblastoma MNDR-E-MI-20978
MNDR hsa-miR-185-5p Uterine corpus endometrial carcinoma MNDR-E-MI-20979
MNDR hsa-miR-185-5p Lymphoma MNDR-E-MI-20980
MNDR hsa-miR-185-5p Cutaneous t cell lymphoma MNDR-E-MI-20981
MNDR hsa-miR-185-5p Estrogen-receptor positive breast cancer MNDR-E-MI-20982
MNDR hsa-miR-185-5p Estrogen-receptor negative breast cancer MNDR-E-MI-20983
MNDR hsa-miR-185-5p Progesterone-receptor positive breast cancer MNDR-E-MI-20984
MNDR hsa-miR-185-5p Progesterone-receptor negative breast cancer MNDR-E-MI-20985
MNDR hsa-miR-185-5p Her2-receptor positive breast cancer MNDR-E-MI-20986
MNDR hsa-miR-185-5p Breast cancer luminal MNDR-E-MI-20987
MNDR hsa-miR-185-5p Anencephaly MNDR-E-MI-20988
MNDR hsa-miR-185-5p Neurofibromatosis 1 MNDR-E-MI-20989
MNDR hsa-miR-185-5p Prostate cancer MNDR-E-MI-20990
MNDR hsa-miR-185-5p Prostate carcinoma MNDR-E-MI-20991
MNDR hsa-miR-185-5p Gastric cancer MNDR-E-MI-20992
MNDR hsa-miR-185-5p Wolfram syndrome MNDR-E-MI-20993
MNDR hsa-miR-185-5p Alzheimer disease MNDR-E-MI-20994
MNDR hsa-miR-185-5p Intracranial aneurysm MNDR-E-MI-20995
MNDR hsa-miR-185-5p Esophageal carcinoma MNDR-E-MI-20996
MNDR hsa-miR-185-5p Dysautonomia familial MNDR-E-MI-20997
MNDR hsa-miR-185-5p Polycystic ovary syndrome MNDR-E-MI-20998
MNDR hsa-miR-185-5p Head and neck cancer MNDR-E-MI-20999
MNDR hsa-miR-185-5p Cardiovascular disease MNDR-E-MI-21000
MNDR hsa-miR-185-5p Moyamoya disease MNDR-E-MI-21001
MNDR hsa-miR-185-5p Lung cancer MNDR-E-MI-21002
MNDR hsa-miR-185-5p Parkinson disease MNDR-E-MI-21003
MNDR hsa-miR-185-5p Breast cancer MNDR-E-MI-21004
MNDR hsa-miR-185-5p Pituitary neoplasms MNDR-E-MI-21005
MNDR hsa-miR-185-5p Pancreatic cancer MNDR-E-MI-21006
MNDR hsa-miR-185-5p Malignant melanoma MNDR-E-MI-21007
MNDR hsa-miR-185-5p Rectum adenocarcinoma MNDR-E-MI-21008
MNDR hsa-miR-185-5p Nephroblastoma MNDR-E-MI-21009
MNDR hsa-miR-185-5p Colon cancer MNDR-E-MI-21010
MNDR hsa-miR-185-5p Colon adenocarcinoma MNDR-E-MI-21011
MNDR hsa-miR-185-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-21012
MNDR hsa-miR-185-5p Ovarian cancer MNDR-E-MI-21013
MNDR hsa-miR-185-5p Acromegaly MNDR-E-MI-21014
MNDR hsa-miR-185-5p Carcinoma ductal breast MNDR-E-MI-21015
MNDR hsa-miR-185-5p Glioblastoma MNDR-E-MI-21016
MNDR hsa-miR-185-5p Glioma MNDR-E-MI-21017
MNDR hsa-miR-185-5p Chronic obstructive pulmonary disease MNDR-E-MI-21018
MNDR hsa-miR-185-5p Chordoma MNDR-E-MI-21019
MNDR hsa-miR-185-5p Amyotrophic lateral sclerosis MNDR-E-MI-21020
MNDR hsa-miR-185-5p Osteosarcoma MNDR-E-MI-21021
MNDR hsa-miR-185-5p Liposarcoma MNDR-E-MI-21022
MNDR hsa-miR-185-5p Meningioma MNDR-E-MI-21023
MNDR hsa-miR-185-5p Liver cancer MNDR-E-MI-21024
MNDR hsa-miR-185-5p Uterine cancer MNDR-E-MI-21025
MNDR hsa-miR-185-5p Cervical adenocarcinoma MNDR-E-MI-21026
MNDR hsa-miR-185-5p Gastric adenocarcinoma MNDR-E-MI-21027
MNDR hsa-miR-185-5p Cervical squamous cell carcinoma MNDR-E-MI-21028
MNDR hsa-miR-185-5p Pituitary adenoma MNDR-E-MI-21029
MNDR hsa-miR-185-5p Lung squamous cell carcinoma MNDR-E-MI-21030
MNDR hsa-miR-185-5p Non-small cell lung cancer MNDR-E-MI-21031
MNDR hsa-miR-185-5p Lung adenocarcinoma MNDR-E-MI-21032
MNDR hsa-miR-185-5p Thyroid carcinoma MNDR-E-MI-21033
MNDR hsa-miR-185-5p Bladder urothelial carcinoma MNDR-E-MI-21034
MNDR hsa-miR-185-5p Myasthenia gravis autoimmune experimental MNDR-E-MI-21035
MNDR hsa-miR-185-5p Carcinoma renal cell MNDR-E-MI-21036
MNDR hsa-miR-185-5p Kidney renal papillary cell carcinoma MNDR-E-MI-21037
MNDR hsa-miR-185-5p Clear cell renal cell carcinoma MNDR-E-MI-21038
MNDR hsa-miR-185-5p Chromophobe renal cell carcinoma MNDR-E-MI-21039
MNDR hsa-miR-185-5p Large cell carcinoma MNDR-E-MI-21040
MNDR hsa-miR-185-5p Esophageal cancer MNDR-E-MI-21041
MNDR hsa-miR-185-5p Liver cirrhosis MNDR-E-MI-21042
MNDR hsa-miR-185-5p Oncocytoma MNDR-E-MI-21043
MNDR hsa-miR-185-5p Stomach carcinoma MNDR-E-MI-21044
MNDR hsa-miR-185-5p Head and neck squamous cell carcinoma MNDR-E-MI-21045
MNDR hsa-miR-185-5p Growth hormone-secreting pituitary adenoma MNDR-E-MI-21046
MNDR hsa-miR-185-5p Fibromyalgia MNDR-E-MI-21047
MNDR hsa-miR-185-5p Encephalomyelitis MNDR-E-MI-21048
MNDR hsa-miR-185-5p Breast invasive carcinoma MNDR-E-MI-21049
MNDR hsa-miR-185-5p Early hepatocellular carcinoma MNDR-E-MI-21050
MNDR hsa-miR-185-5p Malignant pleural mesothelioma MNDR-E-MI-21051
MNDR hsa-miR-185-5p Retinoblastoma MNDR-E-MI-21052
MNDR hsa-miR-185-5p Neuroblastoma MNDR-E-MI-21053
MNDR hsa-miR-185-5p Hodgkin lymphoma MNDR-E-MI-21054
MNDR hsa-miR-185-5p Dementia vascular MNDR-E-MI-21055
MNDR hsa-miR-185-5p Tonsil cancer MNDR-E-MI-21056
MNDR hsa-miR-185-5p Psoriasis MNDR-E-MI-21057
MNDR hsa-miR-185-5p Acute myelocytic leukemia MNDR-E-MI-21058
MNDR hsa-miR-185-5p Colorectal cancer MNDR-E-MI-21059
MNDR hsa-miR-185-5p Multiple myeloma MNDR-E-MI-21060
MNDR hsa-miR-185-5p Ependymoma MNDR-E-MI-21061
MNDR hsa-miR-185-5p Hearing loss noise-induced MNDR-E-MI-21062
MNDR hsa-miR-185-5p Cardiomegaly MNDR-E-MI-21063
MNDR hsa-miR-185-5p Sleep deprivation MNDR-E-MI-21064
MNDR hsa-miR-185-5p Epstein-barr virus infections MNDR-E-MI-21065
MNDR hsa-miR-185-5p Stroke lacunar MNDR-E-MI-21066
MNDR hsa-miR-185-5p Breast cancer her3+ negative MNDR-E-MI-21067
MNDR hsa-miR-185-5p High grade dysplastic nodule MNDR-E-MI-21068
MNDR hsa-miR-185-5p HPV MNDR-E-MI-21069
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCG4 Homo sapiens RR00024860
TOP